Lonza Group AG/ CH0013841017 /
06/06/2024 21:53:26 | Chg. +3.5600 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
565.0000USD | +0.63% | 60 Turnover: 33,510 |
-Bid Size: - | -Ask Size: - | 42.41 bill.USD | - | - |
GlobeNewswire
04/04
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire
16/10/2023
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire
07/09/2023
Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire
02/11/2021
Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strate...
GlobeNewswire
08/09/2021
Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment o...
GlobeNewswire
14/04/2021
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
GlobeNewswire
12/01/2021
Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the...
GlobeNewswire
08/01/2021
Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
GlobeNewswire
23/12/2020
Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
GlobeNewswire
10/11/2020
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal V...
GlobeNewswire
04/09/2020
Institutional Investor Research Publishes 2020 Europe Executive Team Rankings
GlobeNewswire
06/02/2020
Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic...
GlobeNewswire
02/01/2020
Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products
GlobeNewswire
04/12/2019
Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined w...
GlobeNewswire
21/11/2019
Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorder...
GlobeNewswire
14/11/2019
Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test...
GlobeNewswire
29/10/2019
Worldwide Cell Based Assay & High Content Screening Market Forecasts to 2024 - Candidate Growth, Imm...